These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15239787)

  • 1. Mammographic screening and disease presentation of breast cancer patients who die of disease.
    Spencer DB; Potter JE; Chung MA; Fulton J; Hebert W; Cady B
    Breast J; 2004; 10(4):298-303. PubMed ID: 15239787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving size, lymph node metastatic rate, breast conservation, and mortality of invasive breast cancer in Rhode Island women, a well-screened population.
    Coburn NG; Cady B; Fulton JP; Law C; Chung MA
    Breast Cancer Res Treat; 2012 Oct; 135(3):831-7. PubMed ID: 22933028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population.
    Coburn NG; Chung MA; Fulton J; Cady B
    Cancer Control; 2004; 11(4):222-30. PubMed ID: 15284713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent prognostic value of screen detection in invasive breast cancer.
    Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
    J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
    Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
    Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of mammographically detected breast cancers.
    Sener SF; Winchester DJ; Winchester DP; Kurek R; Motykie G; Martz CH; Rabbitt S
    Am Surg; 1999 Aug; 65(8):731-5; discussion 735-6. PubMed ID: 10432082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening matters for young women with breast carcinoma: evidence of downstaging among 42-49-year-old women with a history of previous mammography screening.
    Buseman S; Mouchawar J; Calonge N; Byers T
    Cancer; 2003 Jan; 97(2):352-8. PubMed ID: 12518359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related differences in patients with nonpalpable breast carcinomas.
    Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C
    Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to T classification in tumor-node-metastasis staging of breast cancer.
    Coburn NG; Clarke-Pearson E; Chung MA; Law C; Fulton J; Cady B
    Am J Surg; 2006 Oct; 192(4):434-8. PubMed ID: 16978944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New era in breast cancer. Impact of screening on disease presentation.
    Cady B
    Surg Oncol Clin N Am; 1997 Apr; 6(2):195-202. PubMed ID: 9103207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening interval breast cancers: mammographic features and prognosis factors.
    Burrell HC; Sibbering DM; Wilson AR; Pinder SE; Evans AJ; Yeoman LJ; Elston CW; Ellis IO; Blamey RW; Robertson JF
    Radiology; 1996 Jun; 199(3):811-7. PubMed ID: 8638010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
    Hofvind S; Skaane P; Vitak B; Wang H; Thoresen S; Eriksen L; Bjørndal H; Braaten A; Bjurstam N
    Radiology; 2005 Nov; 237(2):437-43. PubMed ID: 16244251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Breast Cancer Screening Program in Rhode Island.
    Scott HD; DeBuono BA; Fulton JP; Smith RA; Feldman JP
    J Public Health Policy; 1992; 13(1):52-65. PubMed ID: 1629360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral breast cancer: early detection with mammography.
    Roubidoux MA; Helvie MA; Lai NE; Paramagul C
    Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects in mammographic screening. Detection, prediction, recurrence and prognosis.
    Thurfjell MG
    Acta Radiol Suppl; 2001 Dec; 42(424):1-22. PubMed ID: 12040855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.